EYPT

#1999
EyePoint, Inc. - Common Stock
13.5 8 USD
+0.59%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
13.58
13.58
년간 변동
0.12
19.01
일일 변동
+0.59%
월간 변동
+4.38%
6달 변화
-7.37%
년간 변동율
+13.17%
이전 종가
13.5 0
Open
13.5 8
저가
13.5 8
High
13.5 8
양
145
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 1.14 B
  • Employee 214
  • Founded 2000
  • CEO N/A
  • Website www.eyepoint.bio
  • Headquarter Delaware, United States
  • FIGI BBG000F90JX5
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-5.76
주가매출액비율
0.04

EyePoint, Inc. - Common Stock

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

뉴스